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Virilizing carcinoma of adrenal cortex in a female
Familial X-linked Addison's disease (AD) without neurulogical symptoms as an expression of adrenoleukodystrophy (ALO) .
Two brothers (pt. 1 and 2) presented with hyperpigmentation at 5,and AD at 8yrs.Basal cortisol(F) was low or normal (102; 333),but did not respond to ACTH(113;336nmol/l).They were placed on substitution therapy and reevaluated at age 15 and 13 yrs. Puberty had developed in pt.1 (P5,testicular volume 8ml), but not yet in pt.2.Both had no neurological symptoms. ACTH was increased(322;315ng/l) ,F low or normal (236;364) ,and OHA low(4.4;2.lnmol/l) .Serum Ca ,P ,PTH,testosterone,and aldosterone,PRA,plasma and urinary adrenaline and noradrenaline before and after exercise,and LH and FSH before and after LHRH were normal in both.Antibodies against adrenal tissue were absent.A maternal uncle(pt.3) aged 35yrs also had hyperpigmentation since age 4,and AD since age 12yrs. without neurological symptoms,and was on long-standing substitution. Very long chain fatty acids(C24-26) were in the hemizvaote ranae for ALD in The metyrapone test in pituitary dwarfs-determination of serum cortisol and ll-deoxycortisol by high performance liquid chromatography (HPLC)
Children with growth hormone deficiency may also have deficiencies of other pituitary hormones. The pituitary reserve of Corticotropin (ACTH) may be evaluated in the metyrapone test. The purpose of the present study was to investigate the pituitary adrenal axis in a two day oral metyrapone test with simultaneous measurement of serum cortisol (F) and 11 deoxycortisol (S) level by HPLC in thirty children aged 5 -16, with diagnosed growth hormone deficiency. Blood samples were collected before and after metyrapone administration. After metyrapone serum S levels over 8,7 &q/d1 and F below 7 pg/dl excluded ACTH deficiency in 19 patients. Nine patients demostrated absent or subnormal ACTH reserve -fail to rise of S with F below 7 wg/dl. Two patients had no changes In serum levels of both S and F during the test, probably due to inadequate effect of metyrapone. To ensure that sufficientinhibition of cortisol production has occured, it is important to measure F in the serum as well as S. HPLC is therefore a very useful method of corticosteroid analysis especially for metyrapone test. Endocrine complications of ACTH therapy of infantile spasms. At the end of conventional ACTH therapy of infantile spasms sudden deteriorations of the infant's condition and even deaths are not rare. We followed 10 infants during and after carboxyrnethylcellulose ACTH therapy. 80 IU was given at 8 a.m. for 3 weeks and 40 IU for 2 weeks, with tapering during and termination at the end of the 6th week. During therapy 24h urinary cortisol increased 100-fold, morning plasma cortisol did not increase, and plasma aldosterone decreased slightly. After therapy, cortisol and AVP levels fell precipitously, cortisol remained subnormal for >2 weeks. Plasma renin and aldosterone peaked abruptly. Urine flow decreased and body weight increased sharply. Plasma cortisol response to AVP remained decreased for >2 weeks. Plasma cortisol response to ACTH was shortened at 3d and diminished at 1 to 2 weeks, indicating suppression of ACTH secretion. The risk at the end of ACTH therapy appears to be associated with 1) sudden subsidence of cortisol hypersecretion resulting in hypocortisolism and hypomineralocorticoidism 2) abrupt activation of the renin-angiotensin-aldosterone axis subsequent to the hypomineralocorticoidism, and 3) impairment of water excretion subsequent to the hypocortisolism. bromocriptine The probatory treatment with clonidine was not effective. Three months after regular treatment with bromocriptine (7,Smg per day in 5 doses) a dramatic improvement was noticed. Serum cortisol level decreased and itsrh.ythm became normal. A growth smzt, weight loss and lowering of the blood pressure were observed.When the patient was off treatment for 2 1/2 months, serum cortisol concentration increased especially in evening blood samples. She stopped growing, blood pressure increased and she put on weight again. After re-introducing the treatment remarkable improvement occured again.At the age of 12 she had menarche.After ten months of treatment the size of adenoma in CT image did not change, but its density markedly decreased; the patient is closelyfollowed up.
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